Christopher I. Wright serves as Executive at Cyclerion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher I. Wright has executed 9 insider transactions totaling $10.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 8, 2024 involved exercising options for 3,301 shares valued at $0.
Christopher I. Wright currently holds 10,570 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher I. Wright has been a net seller of CYCN stock. They have purchased $0 and sold $10.5K worth of shares.
Christopher I. Wright's most recent insider trade was on Jun 8, 2024, when they sold 3,301 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $23.91 |
| Discretionary |
| Jul 7, 2023 | ALKS | $42.7K | Payment | 1,430 | $29.88 | Discretionary |
| Jul 7, 2023 | ALKS | $0 | Option Exercise | 5,957 | $N/A | Discretionary |
| Jun 8, 2023 | ALKS | $24.5K | Payment | 777 | $31.54 | Discretionary |
| Jun 8, 2023 | ALKS | $2.8K | Payment | 90 | $31.54 | Discretionary |
| Jun 8, 2023 | ALKS | $0 | Option Exercise | 3,236 | $N/A | Discretionary |
| Jun 8, 2023 | ALKS | $0 | Option Exercise | 373 | $N/A | Discretionary |
| Feb 25, 2021 | CYCN | $10.5K | Sale | 2,637 | $3.99 | Discretionary |